Tumor-infiltrating clonal hematopoiesis is associated with adverse clinical outcomes in diffuse large B-cell lymphoma
{{output}}
Tumor-infiltrating clonal hematopoiesis (TI-CH) contributes to progression of non-hematologic cancers. CH is prevalent in peripheral blood of patients with diffuse large B-cell lymphoma (DLBCL), but TI-CH prevalence and clinical relevance remain largely unexpl... ...
